Nuffield Department of Medicine, University of Oxford.
Healthcare Associated Infections Research Group, University of Leeds.
Clin Infect Dis. 2018 Sep 14;67(7):1035-1044. doi: 10.1093/cid/ciy252.
Rates of Clostridium difficile infection vary widely across Europe, as do prevalent ribotypes. The extent of Europe-wide diversity within each ribotype, however, is unknown.
Inpatient diarrheal fecal samples submitted on a single day in summer and winter (2012-2013) to laboratories in 482 European hospitals were cultured for C. difficile, and isolates the 10 most prevalent ribotypes were whole-genome sequenced. Within each ribotype, country-based sequence clustering was assessed using the ratio of the median number of single-nucleotide polymorphisms between isolates within versus across different countries, using permutation tests. Time-scaled Bayesian phylogenies were used to reconstruct the historical location of each lineage.
Sequenced isolates (n = 624) were from 19 countries. Five ribotypes had within-country clustering: ribotype 356, only in Italy; ribotype 018, predominantly in Italy; ribotype 176, with distinct Czech and German clades; ribotype 001/072, including distinct German, Slovakian, and Spanish clades; and ribotype 027, with multiple predominantly country-specific clades including in Hungary, Italy, Germany, Romania, and Poland. By contrast, we found no within-country clustering for ribotypes 078, 015, 002, 014, and 020, consistent with a Europe-wide distribution. Fluoroquinolone resistance was significantly more common in within-country clustered ribotypes (P = .009). Fluoroquinolone-resistant isolates were also more tightly clustered geographically with a median (interquartile range) of 43 (0-213) miles between each isolate and the most closely genetically related isolate, versus 421 (204-680) miles in nonresistant pairs (P < .001).
Two distinct patterns of C. difficile ribotype spread were observed, consistent with either predominantly healthcare-associated acquisition or Europe-wide dissemination via other routes/sources, for example, the food chain.
欧洲各地艰难梭菌感染的发生率差异很大,流行的核糖体类型也不同。然而,每个核糖体类型在整个欧洲范围内的多样性程度尚不清楚。
在 2012 年至 2013 年夏季和冬季的一天,将来自 482 家欧洲医院的住院腹泻粪便样本提交给实验室进行艰难梭菌培养,并对 10 种最常见的核糖体类型的分离株进行全基因组测序。使用中位数的单核苷酸多态性数量的比率,在每个核糖体类型内,使用排列检验评估基于国家的序列聚类,该比率是在一个国家内的分离株之间与不同国家的分离株之间进行比较的。使用时间标度贝叶斯系统发育树来重建每个谱系的历史位置。
测序分离株(n=624)来自 19 个国家。5 种核糖体类型存在国内聚类:核糖体 356 型,仅在意大利;核糖体 018 型,主要在意大利;核糖体 176 型,具有独特的捷克和德国分支;核糖体 001/072 型,包括独特的德国、斯洛伐克和西班牙分支;核糖体 027 型,具有多个主要国家特异性分支,包括匈牙利、意大利、德国、罗马尼亚和波兰。相比之下,我们发现核糖体 078、015、002、014 和 020 型不存在国内聚类,这与欧洲范围内的分布一致。氟喹诺酮类耐药性在国内聚类核糖体中更为常见(P=0.009)。氟喹诺酮类耐药性分离株在地理上也更为紧密聚类,每个分离株与其最密切遗传相关的分离株之间的中位数(四分位间距)为 43(0-213)英里,而非耐药性对之间的中位数为 421(204-680)英里(P<0.001)。
观察到两种不同的艰难梭菌核糖体传播模式,这与主要通过医疗保健相关获得或通过其他途径/来源(例如食物链)在整个欧洲传播一致。